Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion type Assertion NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_head.
- NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion wasGeneratedBy ECO_0000203 NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_provenance.
- NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion wasDerivedFrom befree-2016 NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_provenance.
- NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion SIO_000772 24049181 NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_provenance.
- NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion evidence source_evidence_literature NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_provenance.
- NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_assertion description "[These results suggest that developing drugs that interrupt interactions between Δ2 LHBS and JAB1 can be used to mitigate Δ2 LHBS-associated risks for HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1112023.RAalHC2ZaNQX1XYSrKtDe6Fx6SbUASu24KemC95yblwSk130_provenance.